Skip to main content

Market Overview

264
Articles

Lara Goldstein

Benzinga Staff Writer

September 26, 2022 4:32 PM
In connection with recent stock splits, psychedelics biotech Clearmind Medicine Inc. (OTC Pink: CMNDF) announced it will proceed with the consoli ...
September 26, 2022 4:23 PM
(Part four of a four-part series) In addition to psilocybin’s therapeutic value, ongoing discussion involves other issues such as ...
September 26, 2022 3:52 PM
Clinical-stage developer of psychedelic compounds Tryp Therapeutics Inc. (OTCQB: TRYPF) filed two provisional patent applications - one for ...
September 26, 2022 3:41 PM
Life sciences biotech company Core One Labs Inc. (OTCQB: CLABF) signed a Letter of Intent with GMP-certified manufacturer Medelys Laboratories Interna ...
September 26, 2022 1:39 PM
As news about psychedelics research and successful applications sweeps across the country and abroad, Psyched is back to wrap ...
September 25, 2022 12:16 PM
Origin Therapeutics Holdings Inc. (CSE: ORIG), a psychedelics industry-focused investment issuer, announced that one of its portfolio c ...
September 23, 2022 4:30 PM
Biomind Labs Inc. (OTC: BMNDF), a life sciences company developing medicinal next-generation psychedelics, completed the dose administration of 30 hea ...
September 23, 2022 10:10 AM
The Canadian-based psychedelics company Nirvana Life Sciences Inc. filed a patent for the deuterated form of 7-hydroxymitragynine (D7-h ...
September 22, 2022 3:52 PM
Legal ketamine-assisted therapy for people with diagnosed mental health conditions continues to expand throughout the U.S. and Canada.  Numinus W ...
September 22, 2022 3:22 PM
During a House Ways & Means Committee meeting wherein lawmakers discussed bills concerning worker and family health support access, Rep. ...
September 22, 2022 1:45 PM
Health Canada receives applications concerning clinical trials on a regular basis.  This time, the licensed producer of natural EU-GMP psilo ...
September 22, 2022 10:28 AM
(Part three of a four-part series) Despite ongoing legal setbacks, psychedelics research has reemerged and it is proving that psilocybin red ...
September 21, 2022 2:54 PM
Alberta-based ATMA Journey Centers Inc. has received Health Canada’s approval to move forward with its N500 Phase II psilocybin clinical study i ...
September 21, 2022 1:25 PM
Numerous life sciences companies are now delivering medicines and treatment through at-home kits for patients with mental health condit ...
September 20, 2022 2:28 PM
The clinical trial investigating the effects of MDMA analogs in healthy volunteers led by PI Prof. Dr. Matthias Liechti and supported by psychede ...
September 20, 2022 10:28 AM
(Part two of a four-part series) Regarding small psilocybin doses, a recently published crowd-sourced research site found that 953 people who&nbs ...
September 19, 2022 3:29 PM
Leaders of the Native American Church of North America (NACNA) recently met with several Congressional officials in the hope of directi ...
September 19, 2022 1:20 PM
The Neurology Centre of Toronto (NCT), located in a midtown neighborhood and owned by Numinus Wellness Inc. (OTCQX: NUMIF), is offering keta ...
September 19, 2022 12:59 PM
UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Psyence Group Inc. (OTCQB: PSYGF)’s application to assess ...
September 19, 2022 8:38 AM
(Part one of a four-part series) In recent years, evidence supporting the use of psychedelics for the treatment of unmet mental health disorders ...
September 17, 2022 6:34 PM
HealingMaps, an informative psychedelic therapy search site, announced the closing of a seed round funding for a total $1 million coming from eight in ...
September 17, 2022 6:05 PM
Canadian-based psychedelics company Nova Mentis Life Science Corp. (OTCQB: NMLSF), or NOVA, is collaborating with the Toronto Institute of P ...
September 17, 2022 6:01 PM
Biotech firm leading the Alcohol Use Disorder (AUD) treatment Awakn Life Sciences Corp. (OTCQB: AWKNF) has announced its financial outcomes and busine ...
September 16, 2022 4:05 PM
Wellbeing Digital Sciences Inc. (OTC: KONEF) filed its financial results for the quarter ended July 31, 2022 and provided some insight on their m ...
September 16, 2022 3:10 PM
Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) is advancing its first Phase I/II clinical trial of oral psilocybin for methamphetamine ...
September 16, 2022 12:08 PM
SEVALENT, Bexson Biomedical’s disrupting offer ready for the small molecule injectable market, received patent allowance by the USPTO for &ldquo ...
September 15, 2022 4:51 PM
Oregon voters said yes to all-psychedelics possession decriminalization in 2020’s state ballot, and a recent poll by Data for Progress show ...
September 15, 2022 2:58 PM
Psychedelics mental wellness telehealth company Nue Life Health PBC is now offering Nue Care, a personalized six-month aftercare program to treat the ...
September 15, 2022 2:36 PM
The psychedelics landscape changes quickly. Whether large or small, every biotech company is looking for ways to further advance their research a ...
September 15, 2022 2:29 PM
The Hazel Park city council, the third Michigan city to approve a psychedelics decriminalization bill, is now reaffirming that decision by d ...